Cargando…
Liver transplantation during COVID-19: Adaptive measures with future significance
Following the outbreak of coronavirus disease 2019 (COVID-19), a disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the field of liver transplantation, along with many other aspects of healthcare, underwent drastic changes. Despite an initial increase in waitli...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516488/ https://www.ncbi.nlm.nih.gov/pubmed/36187879 http://dx.doi.org/10.5500/wjt.v12.i9.288 |
_version_ | 1784798719399428096 |
---|---|
author | Gyftopoulos, Argyrios Ziogas, Ioannis A Montenovo, Martin I |
author_facet | Gyftopoulos, Argyrios Ziogas, Ioannis A Montenovo, Martin I |
author_sort | Gyftopoulos, Argyrios |
collection | PubMed |
description | Following the outbreak of coronavirus disease 2019 (COVID-19), a disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the field of liver transplantation, along with many other aspects of healthcare, underwent drastic changes. Despite an initial increase in waitlist mortality and a decrease in both living and deceased donor liver transplantation rates, through the implementation of a series of new measures, the transplant community was able to recover by the summer of 2020. Changes in waitlist prioritization, the gradual implementation of telehealth, and immunosuppressive regimen alterations amidst concerns regarding more severe disease in immunocompromised patients, were among the changes implemented in an attempt by the transplant community to adapt to the pandemic. More recently, with the advent of the Pfizer BNT162b2 vaccine, a powerful new preventative tool against infection, the pandemic is slowly beginning to subside. The pandemic has certainly brought transplant centers around the world to their limits. Despite the unspeakable tragedy, COVID-19 constitutes a valuable lesson for health systems to be more prepared for potential future health crises and for life-saving transplantation not to fall behind. |
format | Online Article Text |
id | pubmed-9516488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-95164882022-09-29 Liver transplantation during COVID-19: Adaptive measures with future significance Gyftopoulos, Argyrios Ziogas, Ioannis A Montenovo, Martin I World J Transplant Minireviews Following the outbreak of coronavirus disease 2019 (COVID-19), a disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the field of liver transplantation, along with many other aspects of healthcare, underwent drastic changes. Despite an initial increase in waitlist mortality and a decrease in both living and deceased donor liver transplantation rates, through the implementation of a series of new measures, the transplant community was able to recover by the summer of 2020. Changes in waitlist prioritization, the gradual implementation of telehealth, and immunosuppressive regimen alterations amidst concerns regarding more severe disease in immunocompromised patients, were among the changes implemented in an attempt by the transplant community to adapt to the pandemic. More recently, with the advent of the Pfizer BNT162b2 vaccine, a powerful new preventative tool against infection, the pandemic is slowly beginning to subside. The pandemic has certainly brought transplant centers around the world to their limits. Despite the unspeakable tragedy, COVID-19 constitutes a valuable lesson for health systems to be more prepared for potential future health crises and for life-saving transplantation not to fall behind. Baishideng Publishing Group Inc 2022-09-18 2022-09-18 /pmc/articles/PMC9516488/ /pubmed/36187879 http://dx.doi.org/10.5500/wjt.v12.i9.288 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Gyftopoulos, Argyrios Ziogas, Ioannis A Montenovo, Martin I Liver transplantation during COVID-19: Adaptive measures with future significance |
title | Liver transplantation during COVID-19: Adaptive measures with future significance |
title_full | Liver transplantation during COVID-19: Adaptive measures with future significance |
title_fullStr | Liver transplantation during COVID-19: Adaptive measures with future significance |
title_full_unstemmed | Liver transplantation during COVID-19: Adaptive measures with future significance |
title_short | Liver transplantation during COVID-19: Adaptive measures with future significance |
title_sort | liver transplantation during covid-19: adaptive measures with future significance |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516488/ https://www.ncbi.nlm.nih.gov/pubmed/36187879 http://dx.doi.org/10.5500/wjt.v12.i9.288 |
work_keys_str_mv | AT gyftopoulosargyrios livertransplantationduringcovid19adaptivemeasureswithfuturesignificance AT ziogasioannisa livertransplantationduringcovid19adaptivemeasureswithfuturesignificance AT montenovomartini livertransplantationduringcovid19adaptivemeasureswithfuturesignificance |